Skip to main content

John Hurrell Will Head Indiana Proteomics Consortium

NEW YORK, July 16-The Indiana Proteomics Consortium will be headed by longtime biotech manager John Hurrell, the consortium said yesterday.


Hurrell will help structure the new consortium by overseeing investigators and developing a management infrastructure.


He was most recently general manager of North Carolina's TriPath Oncology. Prior to that he was president and CEO of FluorRx, which he co-founded after leaving Boehringer Mannheim.


Indiana University, Purdue University and Eli Lilly jointly founded the consortium in February 2002 in order to develop new tools and techniques in proteomics.


Rick Ludwig, the consortium's interim director, will soon return to his work coordinating proteomics research at Lilly.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.